{"schema_version":"secwatch.filing_event.v1","accession":"0001217234-24-000101","form_type":"8-K","ticker":"CDNA","cik":"0001217234","company_name":"CareDx, Inc.","filed_at":"2024-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.886505+00:00","generated_at":"2026-05-30T05:48:24.828909+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CareDx Q3 revenue $82.9M (+23% YoY), raises FY guidance to $327-331M with positive EBITDA $6.9M","bullets":["Revenue $82.9M (+23% YoY); testing services rev $60.8M (+27%); volume 44,600 tests (+16%).","GAAP net loss $7.4M improved from -$23.5M; non-GAAP net income $8.0M; positive adjusted EBITDA $6.9M.","Raised FY2024 revenue guidance to $327-331M (from $320-328M) and adjusted EBITDA to $18-22M (from $9-15M).","DOJ concluded investigation with no finding of wrongdoing; CMS reaffirmed coverage for AlloSure/AlloMap.","Cash $241M, no debt; hired new COO, CCO, and Chief Data/AI Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001217234-24-000101","json":"https://secwatch.observer/filing/0001217234-24-000101.json","markdown":"https://secwatch.observer/filing/0001217234-24-000101.md","text":"https://secwatch.observer/filing/0001217234-24-000101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1217234/000121723424000101/0001217234-24-000101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1217234/000121723424000101/cdna-20241104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:48:24.828909+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}